WAFIK ZAKI: Open Payments
NPI 1033102975 · DENTON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$502 in 23 payments from 9 companies in 2025. Trend: 2023 $292 · 2024 $577 · 2025 $502
Food & beverage: $502
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 4 | $123 |
| PFIZER INC. | 4 | $77 |
| Lilly USA, LLC | 3 | $57 |
| AstraZeneca Pharmaceuticals LP | 3 | $55 |
| ABBVIE INC. | 2 | $46 |
| Exact Sciences Corporation | 2 | $44 |
| Novo Nordisk Inc | 2 | $37 |
| Amgen Inc. | 2 | $35 |
| SANOFI-AVENTIS U.S. LLC | 1 | $28 |
Products named: GARDASIL 9, MOUNJARO, QULIPTA, The Cologuard Plus Collection Kit, PREVNAR 20, AIRSUPRA, Ozempic, TZIELD.
Industry payments across MD — which companies pay providers there.
